You just read:

Janssen Announces Health Canada Approval of CABENUVA™, the First Long-Acting Regimen for the Treatment of HIV

News provided by

Janssen Pharmaceutical Companies of Johnson & Johnson

Mar 20, 2020, 09:42 ET